熱門資訊> 正文
HyMC、BSGM和ADIL均为上市前涨幅股
2024-04-11 20:27
- Gainers: Rallybio (RLYB) +89% shares gain on investment from J&J for rare fetal condition treatment
- Eliem Therapeutics (ELYM) +57% to buy Tenet, announces $120 million private placement
- Biosig Technologies (BSGM) +39%.
- Alpine Immune Sciences (ALPN) +37%.
- Rent the Runway (RENT) +29% Q4 earnings call release
- Vera Therapeutics (VERA) +11%.
- BitFuFu (FUFU) +9%.
- Hycroft Mining Holding (HYMC) +8%.
- Mobile-health Network (MNDR) +7%.
- Zooz Power (ZOOZ) +7%.
- Babcock & Wilcox Enterprises (BW) +7% raises FY24 adjusted EBITDA target to $105M to $115M
- Energy Focus (EFOI) +6%.
- Adial Pharmaceuticals (ADIL) +6%.
- Rail Vision (RVSN) +6% gets $1 mln order out of contract valued at up to $5 mln
- Iczoom Group (IZM) +5%.
More on premarket gainers & stock
- Adial stock rallies 81% on data for alcohol abuse drug
- BioSig Technologies to reduce its internal workforce to cut down costs
- Seeking Alpha’s Quant Rating on Adial Pharmaceuticals
- Historical earnings data for Adial Pharmaceuticals
- Financial information for Adial Pharmaceuticals
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。